Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

NCT02603432

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Anschutz Cancer Center Pavilion Pharmacy Aurora, Colorado, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Colorado Denver, CTO (CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) Aurora, Colorado, United States
View all 382 locations
View Trial Details
Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

NCT04200963

Conditions
Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

NCT03665285

Conditions
Adenocarcinoma, Advanced or Metastatic Solid Tumors, Breast Cancer, +45 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Laura and Isaac Perlmutter Cancer Center New York, United States
View Trial Details
Completed

SOGUG-AVELUMAB_RWD

NCT05700344

Conditions
Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
Locations
  • Complexo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain
  • Complexo Hospitalario Universitario A Coruña A Coruña, Spain
  • Complejo Hospitalario Universitario Albacete Albacete, Spain
  • Complejo Hospitalario Torrecárdenas Almería, Spain
View all 22 locations
View Trial Details
Completed

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

NCT03788746

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site Glendale, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 58 locations
View Trial Details
Completed

Study of the CD40 Agonistic Monoclonal Antibody APX005M

NCT02482168

Conditions
Cancer, Carcinoma, Carcinoma, Transitional Cell, +18 more
Locations
  • City of Hope Duarte, California, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions